DECISION OF THE EEA JOINT COMMITTEE No 112/2021

of 19 March 2021

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/117]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2020/1093 of 24 July 2020 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 13zzze (Commission Implementing Regulation (EU) No 686/2012) of Chapter XV of Annex II to the EEA Agreement:

‘-

32020 R 1093 : Commission Implementing Regulation (EU) 2020/1093 of 24 July 2020 ( OJ L 241, 27.7.2020, p. 13 ).’

Article 2

The text of Implementing Regulation (EU) 2020/1093 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 20 March 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 19 March 2021.

For the EEA Joint Committee

The President

Clara GANSLANDT

( 1 ) OJ L 241, 27.7.2020, p. 13 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/117/oj

ISSN 1977-0677 (electronic edition)